Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis

Comparison of a group of 20 IBM patients with 20 controls matched on age, gender and weight.

Completed

Looking for future studies?

Key information

Conditions

Inclusion Body Myositis Muscular Diseases Musculoskeletal Diseases Myositis Myositis, Inclusion Body Nervous System Diseases Neuromuscular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hopital Pitié-Salpêtrière

Paris, 75013, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age > 18 years old
Written consent

Exclusion criteria

Current infection
Cancer within 1 year
Immune deficiency

Treatment and study plan

Primary outcomes

muscle strength

Time frame: 2 evaluations at an interval of 9 months

Secondary outcomes

immune response

Time frame: 1 measure at inclusion

Sponsors and collaborators

Lead sponsor

Institut de Myologie, France

Other

Collaborators

Assistance Publique - Hôpitaux de Paris

Registry information

Official study title

Evaluation of Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis

Acronym: IBMan

Important dates

Study start: 2009
Primary completion: 2010
Study completion: 2010
First posted: May 12, 2009
Registry last updated: Dec 21, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed